Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN

ALEXION PHARMACEUTICALS, INC.

(ALXN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on ALEXION PHARMACEUTICALS, INC.
12/01/20 | 08:50am Evercore ISI HealthCONx Conference
12/05/20 | 10:00am American Society of Hematology Meeting - Abstract ID #1579
12/05/20 | 10:00am American Society of Hematology Meeting - Abstract ID #756
12/06/20 | 10:00am American Society of Hematology Meeting - Abstract ID #2457
Past events on ALEXION PHARMACEUTICALS, INC.
11/17/20 | 10:00am Stifel Healthcare Conference
10/29/20 | 07:00am Q3 2020 Earnings Call
10/29/20 | 05:30am Q3 2020 Earnings Release
10/25/20 | 04:00pm American Society of Nephrology Kidney Week - Abstract No - SU-OR40
Upcoming sector events for ALEXION PHARMACEUTICALS, INC.
11/30/20 CURALEAF HOLDINGS, INC. : Cowen & Co. Boston Cannabis Conference
12/01/20 ASTRAZENECA PLC : Redburn Virtual Conference
12/01/20 IPSEN S.A. : Capital Markets Day
12/01/20 | 08:50am BAUSCH HEALTH COMPANIES INC. : Evercore ISI HealthCONx Conference
More events
Past sector events for ALEXION PHARMACEUTICALS, INC.
11/24/20 | 08:00am NOVARTIS AG : Capital Markets Day
11/23/20 CSPC PHARMACEUTICAL GROUP LIMITED : Q3 2020 Earnings Release (Projected)
11/22/20 | 09:00pm GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO LTD : Extraordinary Shareholders Meeting
11/20/20 | 11:00am ELI LILLY AND COMPANY : Tirzepatide Phase III Type 2 Diabetes Clinical Trial Results Call
Annual publications
Annual results201520162017201820192020 (e)
Sales
M $
Released
Forecast
Spread
2 604
2 605
-0,06%
3 084
3 089
-0,17%
3 551
3 520
0,89%
4 131
4 058
1,8%
4 991
4 929
1,3%

5 967
Operating income
(EBITDA)
M $
Released
Forecast
Spread
1 322
1 230
7,5%
1 724
1 508
14%
2 098
1 889
11%
2 585
2 498
3,4%
3 167
3 156
0,36%

3 598
Operating profit
(EBIT)
M $
Released
Forecast
Spread
1 156
1 163
-0,62%
1 328
1 353
-1,8%
1 601
1 561
2,6%
2 179
2 109
3,4%
2 790
2 800
-0,37%

3 294
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
498
581
-14%
576
670
-14%
548
585
-6,4%
242
193
25%
2 179
2 082
4,6%

514
Net income
M $
Released
Forecast
Spread
144
226
-36%
399
461
-13%
443
508
-13%
77,6
30,3
157%
2 404
1 982
21%

514
EPS
$
Released
Forecast
Spread
0,67
1,06
-37%
1,76
2,00
-12%
1,97
2,26
-13%
0,35
0,14
159%
10,7
8,81
21%

2,31
Announcement Date02/03/201602/16/201702/08/201802/04/201901/30/2020

Quarterly publications
Previous periodNext period
Quarterly results2019 Q32019 Q42020 Q12020 Q22020 Q32020 Q4 (e)
Sales
M $
Released
Forecast
Spread
1 263
1 238
2,0%
1 384
1 319
4,9%
1 445
1 367
5,7%
1 445
1 273
13%
1 589
1 429
11%

1 514
Operating income
(EBITDA)
M $
Released
Forecast
Spread
817
812
0,67%
797
824
-3,2%
981
885
11%
934
856
9,2%
955
819
17%

791
Operating profit
(EBIT)
M $
Released
Forecast
Spread
725
682
6,3%
707
713
-0,86%
891
745
20%
845
712
19%
880
705
25%

700
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
536
529
1,3%
602
510
18%
664
603
10%
-1 352
498
-372%
667
542
23%

570
Net income
M $
Released
Forecast
Spread
468
453
3,3%
889
477
86%
558
502
11%
-1 068
461
-332%
578
451
28%

455
EPS
$
Released
Forecast
Spread
2,08
1,95
6,7%
4,00
2,09
91%
2,50
2,25
11%
-4,84
2,13
-327%
2,62
2,03
29%

2,17
Announcement Date10/23/201901/30/202005/06/202007/30/202010/29/2020

Financial data source
© 2020 S&P Global Market Intelligence
© 2020 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise